Succeeding in international clinical trials

International trials are vital when conducting research into diseases that affect patients worldwide. Over the last two decades, the number of multi-centre trials has been increasing, with one study estimating an increase from 112 multi-centre trials in 1995 to 1,273 in 2010.

One of the aims of multi-centre randomised controlled trials (RCTs) is to ensure that patients get access to new drugs as quickly as possible. But the globalisation of healthcare research brings new challenges, which pharmaceutical companies, central labs and other life sciences companies must work to overcome. This article examines some of the key challenges which researchers face when carrying out international trials, and discusses potential solutions to help organisations to deliver successful trials with meaningful results. 

Click here to view full article.

View Full Article